| 标题 |
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: Absolute PASI Outcomes Over 52 Weeks in the Phase 3 POETYK PSO-1 Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:SKIN The Journal of Cutaneous Medicine 作者:Mark Lebwohl; Melinda Gooderham; Richard B. Warren; Diamant Thaçi; Peter Foley; et al 出版日期:2023 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)